title: Peritonsillar abscess: the rationale for interval tonsillectomy.
abstract: Although peritonsillar abscess (quinsy) and peritonsillitis are common ENT emergencies, management strategies in the United Kingdom still vary among otolaryngologists. In order to obtain data on the success of the various strategies, we conducted two surveys--one concerned itself with patient outcomes, while the other sought information on physician preferences. The survey of 571 practicing ENT surgeons revealed that 83% advise interval tonsillectomy only for patients who have a history of tonsillitis; they prefer to take a wait-and-see approach for a single attack of quinsy. Conversely, 15% advise a routine interval tonsillectomy following even a single isolated attack of quinsy/peritonsillitis. Only 6.8% still perform a quinsy tonsillectomy in selected cases. Survey responses from 192 adults and 15 children who had been hospitalized for the treatment of quinsy/peritonsillitis revealed that the vast majority of patients who did not undergo an interval tonsillectomy were still asymptomatic 2 to 8 years later. These results indicate that a wait-and-see policy is indeed suitable for most patients who present with an isolated attack of quinsy/peritonsillitis without a history of tonsillitis. We recommend that tonsillectomy be performed as a definitive treatment for quinsy/peritonsillitis in patients who have a history of tonsillitis. Such a history is a reliable indicator of recurrent quinsy or tonsillitis following an attack of quinsy/peritonsillitis in both children and adults. Quinsy tonsillectomy should be reserved for those few patients who do not respond to conservative measures.
authors.affiliation: Department of Otolaryngology, Ipswich Hospital NHS Trust, U.K. rautvivek@hotmail.com
authors.forename: V V
authors.initials: VV
authors.lastname: Raut
authors.forename: M W
authors.initials: MW
authors.lastname: Yung
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents; D002648:Child; D004359:Drug Therapy, Combination / Q000008:administration & dosage; D005260:Female; D006306:Health Surveys; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010036:Otolaryngology / Q000379:methods; D000039:Peritonsillar Abscess / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D011379:Prognosis; D012008:Recurrence; D012042:Registries; D012680:Sensitivity and Specificity; D014068:Tonsillectomy / Q000379:methods* / Q000706:statistics & numerical data*; D014069:Tonsillitis / Q000175:diagnosis / Q000188:drug therapy / Q000601:surgery*; D016896:Treatment Outcome; D006113:United Kingdom
chemical_list: D000900:Anti-Bacterial Agents